Cannabinoid Receptor Agonists
- Name
- Cannabinoid Receptor Agonists
- Accession Number
- DBCAT000909
- Description
Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS.
- Drugs
Drug Drug Description Dronabinol A synthetic delta-9-THC used in the treatment of anorexia and weight loss in HIV patients as well as nausea and vomiting in cancer chemotherapy. Nabiximols In Canada, Sativex has received a Notice of Compliance (NOC) for use as an as adjunctive treatment for symptomatic relief of spasticity in patients with multiple sclerosis (MS) who have... GW842166 GW842166X has been used in trials studying the treatment of Pain, Analgesia, Inflammation, Osteoarthritis, and Pain, Inflammatory, among others. Taranabant Investigated for use/treatment in obesity. Lenabasum Ajulemic acid has been used in trials studying the treatment of Cystic Fibrosis, Dermatomyositis, and Diffuse Cutaneous Systemic Sclerosis. Oleic monoethanolamide Not Available LY2828360 LY2828360 is under investigation in clinical trial NCT01319929 (A Study of LY2828360 in Patients With Osteoarthritic Knee Pain). Onternabez Not Annotated - Drugs & Drug Targets